Western Michigan University Research Foundation and Biosciences Research and Commercialization Center help Pennsylvania University-founded life sciences start up raise $2m.

The antibiotics developer backed by SR One and MedImmune Ventures postponed its initial public offering a day after it halved the planned price of its float earlier this month.

Sue Siegel, a venture capital, start-up and corporate veteran, most recently a general partner at Mohr Davidow Ventures, moves in to head up GE's $6bn healthcare programme.

Mitralign, a US-based heart treatment company, raises its fourth round of funding, in a deal led by Forbion Capital Partners, which spun off from Dutch-based bank ABN Amro.

Industry legend: Davis cycles into Global Corporate Venturing's hall of fame.

The former Biologics and Clinical Therapies division of Smith & Nephew spins off with backing from Essex Woodlands and its former parent.

The biopharmaceutical company backed by the corporate venturing units of Pfizer, Novartis and Johnson & Johnson increases the size of its latest round.

Harvard Medical School fellow Anthony Philippakis, who is "passionate about translating the insights from the Human Genome Project into clinical medicine" joins Google's corporate venturing unit

Yale professor Craig Crews says the partnershop reflects "a new paradigm" of how academics and the pharmaceutical industry can partner.

Burrill & Company identified more than $2.6bn in expected funding through nine initiatives announced since the end of February to end-March.